ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Heng Ma
Matched on ORCID iD 0000-0002-8729-8430; OpenAlex author ID A5100661727. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2023: 2 papers
Papers 2
- Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-023-01188-z↗
- The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/thno.86547↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianlong Chen · 2 shared papers, 2023 · strength 0.36
- Paper The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic du… DOI 10.7150/thno.86547↗
- Paper Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal a… DOI 10.1038/s41418-023-01188-z↗
- Shuangni Yu · 2 shared papers, 2023 · strength 0.36
- Paper The spatial coexistence of TIGIT/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic du… DOI 10.7150/thno.86547↗
- Paper Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal a… DOI 10.1038/s41418-023-01188-z↗
- Jie Chen · 1 shared paper, 2023 · strength 0.18
- Y. Liu · 1 shared paper, 2023 · strength 0.18
- Jie Chen · 1 shared paper, 2023 · strength 0.18
- Yue Zhang · 1 shared paper, 2023 · strength 0.18
- Wei‐Min Tong · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.